Inclusion criteria |
Aged ≥18 |
Vitamin C deficiency (due to the underlying cancer disease or treatment) |
Previously confirmed cancer diagnosis with previous or current radiation- and/or chemotherapy |
Total lymphocyte count <1500/μL |
Treatment with iv vitamin C 7.5 g once a week, for a total of 4 doses |
Patient's statement of agreement to use and publish their data for the observational study |
Exclusion criteria (anamnestic) |
Patients who received colony-stimulating factor |
Patients not completing all four doses of iv vitamin C |
Oxalate-urolithiasis, nephrolithiasis |
Renal insufficiency |
Iron-storage disease (thalassemia, hämochromatosis, sideroblastic anaemia) |
Erythrocytic glucose-6-phosphate-dehydrogenase-deficiency |
Pregnancy and lactation |